Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New device combo aims to tame tough heart failure

NCT ID NCT07399587

First seen Feb 10, 2026 · Last updated May 25, 2026 · Updated 17 times

Summary

This study looks at using two devices together to help people with severe heart failure. One device measures pressure in the lung artery, and the other stimulates nerves to improve heart function. About 15 adults with NYHA Class III heart failure will be followed for over a year to see if their symptoms and test results improve.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE NYHA CLASS III are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Peconic Bay Medical Center

    RECRUITING

    Riverhead, New York, 11901, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.